Literature DB >> 32522833

Influenza Suppresses Neutrophil Recruitment to the Lung and Exacerbates Secondary Invasive Pulmonary Aspergillosis.

Joshua M Tobin1, Kara L Nickolich1, Krishnaveni Ramanan1, Matthew J Pilewski1, Kristina D Lamens2, John F Alcorn3, Keven M Robinson4.   

Abstract

Aspergillus fumigatus is an environmental fungus that can cause invasive pulmonary aspergillosis when spores are inhaled into the respiratory tract and invade airway or lung tissue. Influenza is a common respiratory virus that can cause severe respiratory disease, and postinfluenza invasive pulmonary aspergillosis, which is becoming a well-recognized clinical problem, typically occurs in critically ill patients. Mice challenged with influenza A PR/8/34 H1N1 and subsequently challenged with A. fumigatus had increased fungal burden, viral burden, inflammation, and mortality compared with single infected mice. Neutrophil recruitment in the lung of superinfected mice was decreased; however, mice were not neutropenic, and there was no difference in absolute blood neutrophils between groups. Additionally, CXCL1 and CXCL2 were decreased in lungs of superinfected mice compared with controls. IFN levels were increased in mice that received influenza, and deletion of STAT1 resulted in decreased fungal burden, increased airway and lung neutrophils, and increased CXCL1 compared with wild-type mice, whereas deletion of STAT2 did not change fungal burden or airway neutrophilia compared with wild-type mice. These data demonstrate a mechanism by which influenza A-induced STAT1 signaling inhibits neutrophil recruitment and increases susceptibility to postinfluenza invasive pulmonary aspergillosis.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32522833      PMCID: PMC7416629          DOI: 10.4049/jimmunol.2000067

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

Review 1.  Therapy for fungal diseases: opportunities and priorities.

Authors:  David W Denning; William W Hope
Journal:  Trends Microbiol       Date:  2010-03-06       Impact factor: 17.079

2.  Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.

Authors:  Edward Sionov; Sonia Mendlovic; Esther Segal
Journal:  J Antimicrob Chemother       Date:  2005-07-08       Impact factor: 5.790

3.  Influenza A virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production.

Authors:  Keven M Robinson; Kevin J McHugh; Sivanarayana Mandalapu; Michelle E Clay; Benjamin Lee; Erich V Scheller; Richard I Enelow; Yvonne R Chan; Jay K Kolls; John F Alcorn
Journal:  J Infect Dis       Date:  2013-09-26       Impact factor: 5.226

4.  Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults.

Authors:  David W Denning; Alex Pleuvry; Donald C Cole
Journal:  Med Mycol       Date:  2012-12-04       Impact factor: 4.076

Review 5.  Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature.

Authors:  Melisa M Shah; Eric I Hsiao; Carl M Kirsch; Amit Gohil; Supriya Narasimhan; David A Stevens
Journal:  Diagn Microbiol Infect Dis       Date:  2018-02-02       Impact factor: 2.803

6.  Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain.

Authors:  Danielle Califano; Yoichi Furuya; Dennis W Metzger
Journal:  J Immunol       Date:  2018-05-14       Impact factor: 5.422

7.  Type III interferon is a critical regulator of innate antifungal immunity.

Authors:  Vanessa Espinosa; Orchi Dutta; Constance McElrath; Peicheng Du; Yun-Juan Chang; Bryan Cicciarelli; Amy Pitler; Ian Whitehead; Joshua J Obar; Joan E Durbin; Sergei V Kotenko; Amariliz Rivera
Journal:  Sci Immunol       Date:  2017-10-06

Review 8.  Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment.

Authors:  Lore Vanderbeke; Isabel Spriet; Christine Breynaert; Bart J A Rijnders; Paul E Verweij; Joost Wauters
Journal:  Curr Opin Infect Dis       Date:  2018-12       Impact factor: 4.915

9.  The role of neutrophils during mild and severe influenza virus infections of mice.

Authors:  Michelle D Tate; Lisa J Ioannidis; Ben Croker; Lorena E Brown; Andrew G Brooks; Patrick C Reading
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

10.  Influenza Coinfection: Be(a)ware of Invasive Aspergillosis.

Authors:  Paul E Verweij; Roger J M Brüggemann; Joost Wauters; Bart J A Rijnders; Tom Chiller; Frank L van de Veerdonk
Journal:  Clin Infect Dis       Date:  2020-01-02       Impact factor: 9.079

View more
  11 in total

Review 1.  Mechanistic Basis of Super-Infection: Influenza-Associated Invasive Pulmonary Aspergillosis.

Authors:  Keven Mara Robinson
Journal:  J Fungi (Basel)       Date:  2022-04-22

2.  Lipidation of Haemophilus influenzae Antigens P6 and OMP26 Improves Immunogenicity and Protection against Nasopharyngeal Colonization and Ear Infection.

Authors:  Ravinder Kaur; Michael Pichichero
Journal:  Infect Immun       Date:  2022-04-18       Impact factor: 3.609

Review 3.  Neutrophils in respiratory viral infections.

Authors:  Cecilia Johansson; Freja C M Kirsebom
Journal:  Mucosal Immunol       Date:  2021-03-23       Impact factor: 7.313

4.  IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Fengming Ding; Lei Han; Qiang Fu; Xinxin Fan; Rong Tang; Chengjian Lv; Yishu Xue; Xue Tian; Min Zhang
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

Review 5.  Pathogenesis of Respiratory Viral and Fungal Coinfections.

Authors:  Fabián Salazar; Elaine Bignell; Gordon D Brown; Peter C Cook; Adilia Warris
Journal:  Clin Microbiol Rev       Date:  2021-11-17       Impact factor: 26.132

6.  Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model.

Authors:  Laura Seldeslachts; Lore Vanderbeke; Astrid Fremau; Agustin Reséndiz-Sharpe; Cato Jacobs; Bo Laeveren; Tessa Ostyn; Lieve Naesens; Matthias Brock; Frank L Van De Veerdonk; Stephanie Humblet-Baron; Erik Verbeken; Katrien Lagrou; Joost Wauters; Greetje Vande Velde
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 7.  Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta-analysis.

Authors:  Changcheng Shi; Qiyuan Shan; Junbo Xia; Liusheng Wang; Linling Wang; Lei Qiu; Yaping Xie; Nengming Lin; Limin Wang
Journal:  Mycoses       Date:  2021-12-22       Impact factor: 4.931

8.  Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.

Authors:  Lore Vanderbeke; Nico A F Janssen; Roger J M Brüggemann; Joost Wauters; Dennis C J J Bergmans; Marc Bourgeois; Jochem B Buil; Yves Debaveye; Pieter Depuydt; Simon Feys; Greet Hermans; Oscar Hoiting; Ben van der Hoven; Cato Jacobs; Katrien Lagrou; Virginie Lemiale; Piet Lormans; Johan Maertens; Philippe Meersseman; Bruno Mégarbane; Saad Nseir; Jos A H van Oers; Marijke Reynders; Bart J A Rijnders; Jeroen A Schouten; Isabel Spriet; Karin Thevissen; Arnaud W Thille; Ruth Van Daele; Frank L van de Veerdonk; Paul E Verweij; Alexander Wilmer
Journal:  Intensive Care Med       Date:  2021-05-29       Impact factor: 17.440

Review 9.  Beyond "Big Eaters": The Versatile Role of Alveolar Macrophages in Health and Disease.

Authors:  Miriam Hetzel; Mania Ackermann; Nico Lachmann
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

10.  Overcome Double Trouble: Baloxavir Marboxil Suppresses Influenza Thereby Mitigating Secondary Invasive Pulmonary Aspergillosis.

Authors:  Laura Seldeslachts; Cato Jacobs; Birger Tielemans; Eliane Vanhoffelen; Lauren Van der Sloten; Stephanie Humblet-Baron; Lieve Naesens; Katrien Lagrou; Erik Verbeken; Joost Wauters; Greetje Vande Velde
Journal:  J Fungi (Basel)       Date:  2021-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.